Evidence map›Paper›PMID 22967108›Full record

ArticleJournal of neuroendocrinology2013

Phosphatidylinositol 3-kinase is an upstream regulator of the phosphodiesterase 3B pathway of leptin signalling that may not involve activation of Akt in the rat hypothalamus.

A Sahu, K Koshinaka, M Sahu

Abstract read
In one paragraph

Article in Journal of neuroendocrinology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. The Mechanism of Leptin Resistance in Obesity and Therapeutic Perspective.Advances in experimental medicine and biology · 2024
    Review
  2. Leptin signaling and leptin resistance.Medical review (2021) · 2022
    Review
  3. Article
  4. Molecular Mechanisms of Hypothalamic Insulin Resistance.International journal of molecular sciences · 2019
    Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

A SahuDepartment of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. asahu@pitt.edu
K Koshinaka
M Sahu
University of Pittsburgh · US

Funding

Mechanisms of Leptin Signaling in the HypothalamusR01DK061499 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SAHU, ABHIRAM · 2003 to 2007
$1.4M
Phosphodiesterase-3B Signaling in the Hypothalamus and ObesityR01DK078068 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SAHU, ABHIRAM · 2010 to 2013
$1.3M
NIDDK NIH HHS DK61499NIDDK NIH HHS DK78068NIDDK NIH HHS R01 DK061499NIDDK NIH HHS R01 DK078068
6 · The paper itself

Abstract

Leptin, the product of the obese gene, regulates energy homeostasis by acting primarily at the level of the hypothalamus. Leptin action through its receptor involves various pathways, including the signal transducer and activator of transcription (STAT)3, phosphatidylinositol 3-kinase (PI3K), and phosphodiesterase 3B (PDE3B)-cAMP signalling in the central nervous system and peripheral tissues. In the hypothalamus, leptin stimulates STAT3 activation, and induces PI3K and PDE3B activities, among others. We have previously demonstrated that PDE3B activation in the hypothalamus is critical for transducing the anorectic and body weight reducing effects of leptin. Similarly, PI3K has been implicated to play a critical role in leptin signalling in the hypothalamus. Although, in the insulin signalling pathway, PI3K is known to be an upstream regulator of PDE3B in non-neuronal tissues, it is still unknown whether this is also the case for leptin signalling in the hypothalamus. To address this possibility, the effect of wortmannin, a specific PI3K inhibitor, was examined on leptin-induced PDE3B activity in the hypothalamus of male rats. Intracerebroventricular injection of leptin (4 μg) significantly increased PDE3B activity by two-fold in the hypothalamus as expected. However, previous administration of wortmannin completely reversed the stimulatory effect of leptin on PDE3B activity in the hypothalamus. To investigate whether leptin stimulates phospho (p)-Akt levels and that there might be a possible upstream regulator of PDE3B, we examined the effects of i.c.v. leptin on p-Akt levels in the hypothalamus and compared them with the known stimulatory effect of insulin on p-Akt. We observed that insulin increased p-Akt levels but leptin failed to do so, although it increased p-STAT3 levels, in the rat hypothalamus. Immunocytochemistry confirmed the biochemical findings in that leptin failed but insulin increased the number of p-Akt positive cells in various hypothalamic nuclei. Taken together, these results implicate PI3K but not Akt as an upstream regulator of the PDE3B pathway of leptin signalling in the rat hypothalamus.

Indexed as

AndrostadienesAnimalsCyclic Nucleotide Phosphodiesterases, Type 3HypothalamusInsulinLeptinMaleOncogene Protein v-aktPhosphatidylinositol 3-KinasePhosphodiesterase InhibitorsPhosphorylationRatsRats, Sprague-DawleySignal TransductionSTAT3 Transcription FactorWortmanninAndrostadienesCyclic Nucleotide Phosphodiesterases, Type 3InsulinLeptinOncogene Protein v-aktPhosphatidylinositol 3-KinasePhosphodiesterase InhibitorsStat3 protein, ratSTAT3 Transcription FactorWortmannin

Identifiers

PMID22967108
PMCPMC3549038
OpenAlexW2165286012

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.